Behcet Syndrome: all 138 studies
Page 2 of 2. Open to participants first (43), then studies with results posted, then the rest; newest registration first within each.
- Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's DiseaseCompletedNCT03531385
- Anti IL-18 (GSK1070806) in Behcet's DiseaseStatus unknownNCT03522662Phase 2
- Frequency of Fibromyalgia in Behcet DiseaseCompletedNCT03514056
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT03410290
- Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet DiseaseCompletedNCT03371095Phase 3
- Dietary Interventions and Butyrate Production in Behçet's PatientsCompletedNCT03274648Not applicable
- Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography AngiographyCompletedNCT03264391
- Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease UveitisCompletedNCT03209219Phase 3
- A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) PatientsCompletedNCT02687828
- Uveitis/Intraocular Inflammatory Disease Biobank (iBank)CompletedNCT02656381
- Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet DiseaseCompletedNCT02648581Phase 2
- Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical StudyCompletedNCT02620618Phase 1/2
- A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's DiseaseCompletedNCT02505568Phase 3
- Impact of Vasculitis on Employment and IncomeCompletedNCT02476292
- Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease UveitisTerminatedNCT02258867Phase 3
- VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT02190942
- Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
- Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
- Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
- Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 2
- Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)TerminatedNCT01965145Phase 3
- Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesStatus unknownNCT01952275
- MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASECompletedNCT01780363
- The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's DiseaseCompletedNCT01720628
- A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's SyndromeCompletedNCT01693640Early Phase 1
- Behçet's Disease and Eosinophil Cationic ProteinCompletedNCT01584778
- Efficacy of Humira in Behcet Patients With ArthritisCompletedNCT01497717Phase 3
- The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's DiseaseStatus unknownNCT01306955Phase 4
- A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's DiseaseWithdrawnNCT01211977Phase 1/2
- Immunogenetic Mechanisms in Behcet's DiseaseTerminatedNCT01109433
- Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's DiseaseStatus unknownNCT00931957Not applicable
- Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's DiseaseStatus unknownNCT00720928Phase 4
- Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's DiseaseCompletedNCT00700297Phase 2
- Psychological Symptoms in Patients With Behcet's Disease by SCL90-RCompletedNCT00699985
- Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's DiseaseCompletedNCT00664599Phase 2
- Stem Cell Transplantation in Ocular Lesions of Behcet's DiseaseTerminatedNCT00550498Phase 1
- Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)CompletedNCT00167583Phase 3
- HAT in Eye Complications of Behcet's DiseaseCompletedNCT00001865Phase 2